TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vifor Pharma Nordiska AB
Closing information (x1000 EUR)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
28,635
|
29,070
|
36,859 |
| Financial expenses |
81
|
82
|
120 |
| Earnings before taxes |
1,119
|
2,308
|
666 |
| EBITDA |
1,132
|
2,308
|
807 |
| Total assets |
29,565
|
33,283
|
21,100 |
| Current assets |
29,565
|
33,275
|
21,077 |
| Current liabilities |
12,382
|
17,243
|
7,389 |
| Equity capital |
6,865
|
5,917
|
3,958 |
| - share capital |
18
|
18
|
17 |
| Employees (average) |
34
|
38
|
46 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
23.2%
|
17.8%
|
18.8% |
| Turnover per employee |
842
|
765
|
801 |
| Profit as a percentage of turnover |
3.9%
|
7.9%
|
1.8% |
| Return on assets (ROA) |
4.1%
|
7.2%
|
3.7% |
| Current ratio |
238.8%
|
193.0%
|
285.2% |
| Return on equity (ROE) |
16.3%
|
39.0%
|
16.8% |
| Change turnover |
-990
|
-9,192
|
16,176 |
| Change turnover % |
-3%
|
-24%
|
78% |
| Chg. No. of employees |
-4
|
-8
|
6 |
| Chg. No. of employees % |
-11%
|
-17%
|
15% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.